These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22045993)

  • 21. [Campaign against counterfeit drugs].
    Warnet S
    Rev Infirm; 2013; (193):8. PubMed ID: 24245394
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent initiatives of the European Union on the field of drug use and trafficking].
    Salazar L
    Ann Ist Super Sanita; 2002; 38(3):319-21. PubMed ID: 12645184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The international drug control cooperation policy of the European Community: a personal view.
    van der Vaeren C
    Bull Narc; 1994; 46(2):1-7. PubMed ID: 7866394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Medical Product Agency's work and economics--a comment].
    Ahlqvist Rastad J; Salmonson T
    Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382
    [No Abstract]   [Full Text] [Related]  

  • 27. Counterfeit drugs pose growing health threat.
    Traynor K
    Am J Health Syst Pharm; 2010 Nov; 67(22):1896, 1898. PubMed ID: 21048204
    [No Abstract]   [Full Text] [Related]  

  • 28. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
    Hurtado RL; Lasmar MC
    Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of the Pompidou Group of the Council of Europe in combating drug abuse and illicit drug trafficking.
    Brulé C
    Bull Narc; 1983; 35(4):73-7. PubMed ID: 6563929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 32. International Regulatory Compliance.
    Mascaro J
    J Pharm Sci Technol; 1994; 48(1):7-10. PubMed ID: 8004420
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulatory approaches to new psychoactive substances (NPS) in the European Union.
    Hughes B; Griffiths P
    Addiction; 2014 Oct; 109(10):1591-3. PubMed ID: 25163707
    [No Abstract]   [Full Text] [Related]  

  • 34. We need to 'get real' about counterfeit medicine.
    DeCola PR
    Int Nurs Rev; 2010 Sep; 57(3):275-6. PubMed ID: 20796051
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intercantonal Office for Drug Control. Its history, activities, current problems].
    Méroz JC
    Rev Med Suisse Romande; 1991 Nov; 111(11):951-4. PubMed ID: 1749893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Front line of combating counterfeit medicines, globally and locally].
    Kimura K
    Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
    [No Abstract]   [Full Text] [Related]  

  • 37. Tooth-whitening directive finally being put to the vote.
    Feeney T
    J Ir Dent Assoc; 2010; 56(3):122-3. PubMed ID: 20617766
    [No Abstract]   [Full Text] [Related]  

  • 38. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [European Council: new legal dispositions on drugs and drug traffickers].
    CICIAMS Nouv; 1973; (3):28-32. PubMed ID: 4491675
    [No Abstract]   [Full Text] [Related]  

  • 40. Study on exempted preparations.
    Halbach H
    Bull Narc; 1983; 35(1):17-40. PubMed ID: 6555054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.